Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000047

Chief Medical Officer sold 11,366 shares at an average $14.53 ($165,185)

  • Chief Medical Officer acquired 6,348 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-04-14 Option exercise 10b5-1 +6,348 $1.08 $6,856 123,052 D
Rodman David Malcom Chief Medical Officer 2025-04-14 Sale 10b5-1 −2,966 $13.69 $40,613 120,086 D
Rodman David Malcom Chief Medical Officer 2025-04-14 Sale 10b5-1 −8,400 $14.83 $124,572 111,686 D
Derivatives
Rodman David Malcom Chief Medical Officer 2025-04-14 Option exercise · Stock Option 10b5-1 −6,348 107,926 D
Open-market sales · 11,366 sh · avg $14.53 · $165,185
Loading xslF345X05/wk-form4_1744763954.xml…